Microneedling and Serum for Acne

Overseen By COREY LOUIS HARTMAN

Age: 18 - 65

Sex: Female

Trial Phase: Phase 2 & 3

Sponsor: Equipmed USA LLC

Disqualifiers: Herpes, Bleeding disorders, Connective tissue, others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Prior Safety Data This treatment has passed at least one previous human trial

Compensation: Varies

Number of Visits: Unknown

Duration: 12 weeks

10 Participants Needed

Trial Summary

What is the purpose of this trial?

This study is conducted to check how well the Dermapen 4™ microneedling device works with MG-CLR serum for treating acne over 12 weeks.

Eligibility Criteria

This trial is for individuals with acne who are looking to improve their skin condition. Specific eligibility criteria have not been provided, so it's best to contact the study organizers for detailed requirements.

Inclusion Criteria

Fitzpatrick skin phototype I to VI

I haven't treated my acne with any methods for the last month.

I am a woman aged between 18 and 45.

Exclusion Criteria

Subjects known to have bleeding and clotting disorders (self-declared)

I currently have an active cold sore infection.

Subjects known to have connective tissue disorders

Timeline

Screening

Participants are screened for eligibility to participate in the trial

1 week

Treatment

Participants receive treatment with the Dermapen 4™ microneedling device and MG-CLR serum for acne over 12 weeks

12 weeks

Follow-up

Participants are monitored for safety and effectiveness after treatment

1 week

Treatment Details

Interventions

• Dermapen 4™

Trial Overview The effectiveness of Dermapen 4™ microneedling device in combination with MG-CLR serum is being tested over a period of 12 weeks to treat acne.

Participant Groups

Group I: A single arm, full face clinical study. Experimental Treatment 1 Intervention

Dermapen 4 in conjunction with MG-CLR serum

Who Is Running the Clinical Trial?

Equipmed USA LLC

Lead Sponsor

Trials

1

Recruited

10+